This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
5ign
From Proteopedia
(Difference between revisions)
| Line 3: | Line 3: | ||
<StructureSection load='5ign' size='340' side='right'caption='[[5ign]], [[Resolution|resolution]] 1.70Å' scene=''> | <StructureSection load='5ign' size='340' side='right'caption='[[5ign]], [[Resolution|resolution]] 1.70Å' scene=''> | ||
== Structural highlights == | == Structural highlights == | ||
| - | <table><tr><td colspan='2'>[[5ign]] is a 2 chain structure with sequence from [ | + | <table><tr><td colspan='2'>[[5ign]] is a 2 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5IGN OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=5IGN FirstGlance]. <br> |
| - | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=6B2:N-[(2R,3S)-2-(4-CHLOROPHENYL)-1-(1,4-DIMETHYL-2-OXO-1,2-DIHYDROQUINOLIN-7-YL)-6-OXOPIPERIDIN-3-YL]-2-METHYLPROPANE-1-SULFONAMIDE'>6B2</scene> | + | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 1.7Å</td></tr> |
| - | + | <tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=6B2:N-[(2R,3S)-2-(4-CHLOROPHENYL)-1-(1,4-DIMETHYL-2-OXO-1,2-DIHYDROQUINOLIN-7-YL)-6-OXOPIPERIDIN-3-YL]-2-METHYLPROPANE-1-SULFONAMIDE'>6B2</scene></td></tr> | |
| - | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[ | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=5ign FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5ign OCA], [https://pdbe.org/5ign PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=5ign RCSB], [https://www.ebi.ac.uk/pdbsum/5ign PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=5ign ProSAT]</span></td></tr> |
</table> | </table> | ||
== Function == | == Function == | ||
| - | [ | + | [https://www.uniprot.org/uniprot/BRD9_HUMAN BRD9_HUMAN] May play a role in chromatin remodeling and regulation of transcription. |
==See Also== | ==See Also== | ||
| Line 15: | Line 15: | ||
__TOC__ | __TOC__ | ||
</StructureSection> | </StructureSection> | ||
| - | [[Category: | + | [[Category: Homo sapiens]] |
[[Category: Large Structures]] | [[Category: Large Structures]] | ||
| - | [[Category: Arrowsmith | + | [[Category: Arrowsmith CH]] |
| - | [[Category: Bountra | + | [[Category: Bountra C]] |
| - | [[Category: Brennan | + | [[Category: Brennan PE]] |
| - | [[Category: Clark | + | [[Category: Clark PGK]] |
| - | + | [[Category: Dixon DJ]] | |
| - | [[Category: Dixon | + | [[Category: Edwards AM]] |
| - | [[Category: Edwards | + | [[Category: Fedorov O]] |
| - | [[Category: Fedorov | + | [[Category: Knapp S]] |
| - | [[Category: Knapp | + | [[Category: Krojer T]] |
| - | [[Category: Krojer | + | [[Category: Newman JA]] |
| - | [[Category: Newman | + | [[Category: Nunez-Alonso G]] |
| - | [[Category: Nunez-Alonso | + | [[Category: Picaud S]] |
| - | [[Category: Picaud | + | [[Category: Tallant C]] |
| - | + | [[Category: Vieira LCC]] | |
| - | [[Category: Tallant | + | [[Category: Von Delft F]] |
| - | [[Category: Vieira | + | |
| - | [[Category: | + | |
| - | + | ||
| - | + | ||
| - | + | ||
Current revision
Crystal structure of human BRD9 bromodomain in complex with LP99 chemical probe
| |||||||||||
Categories: Homo sapiens | Large Structures | Arrowsmith CH | Bountra C | Brennan PE | Clark PGK | Dixon DJ | Edwards AM | Fedorov O | Knapp S | Krojer T | Newman JA | Nunez-Alonso G | Picaud S | Tallant C | Vieira LCC | Von Delft F
